Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Joule Debuts Biofuel Technology, Genzyme Cleans House, Avila Banks $30M, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
07/29/09 |
Boston
|
|
$8M More for Acquia, Novartis-Alnylam Collaboration Continues, Virtualization Firm Akiba Acquires $6.53M, & More Boston-Area Deals News
|
Rebecca Zacks |
07/24/09 |
Boston
|
|
Archemix Signs MicroRNA Deal
|
Luke Timmerman |
07/23/09 |
Boston
|
|
Biogen Founder Retires From Board, Biopure Goes Broke, Epix Saga Ends, & More Boston-Area Life Sciences News
|
Eric Hal Schwartz |
07/22/09 |
Boston
|
|
Dicerna, Archemix Team Up to Make Souped Up RNAi Combo Drugs
|
Luke Timmerman |
07/21/09 |
Boston
|
|
Agios Lands Genentech Cancer Drug Leader as New CEO
|
Luke Timmerman |
05/27/09 |
Boston
|
|
Archemix Names Bate CEO
|
Ryan McBride |
05/06/09 |
Boston
|
|
Exact Teams With Genzyme, Shrugs off Sequenom; Virtual Computer Reels in $15M; Beacon Power Inks National Grid Agreement; & More Boston-Area Deal News
|
Rebecca Zacks |
01/30/09 |
Boston
|
|
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
01/28/09 |
Boston
|
|
NitroMed Takes Buyout Offer from Deerfield, Dumps Archemix at the Altar
|
Ryan McBride |
01/27/09 |
Boston
|
|
NitroMed Delays Vote on Drug Sale
|
Ryan McBride |
01/14/09 |
Boston
|
|
Archemix Partners with GSK, EMC Acquires SourceLabs Assets, Satori Raises $22M to Take on Alzheimer’s, & More Boston-Area Deals News
|
Rebecca Zacks |
01/09/09 |
Boston
|
|
New RNAi Drugs, Major Cutbacks at Targanta, Big Partnerships for Arqule and Archemix, & More Boston-Area Life Sciences News
|
Wade Roush |
12/24/08 |
Boston
|
|
Archemix Secures Partnership with Glaxo to Develop Drugs for Inflammatory Diseases
|
Luke Timmerman |
12/23/08 |
Boston
|
|
Novartis Deal Could Boost Ascent by $200M, Ariad’s Boardroom Drama Comes to Light, Targanta Takes Another Hit, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/10/08 |
Boston
|
|
NitroMed Gets Buyout Offer
|
Ryan McBride |
12/04/08 |
Boston
|
|
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News
|
Rebecca Zacks |
11/24/08 |
Boston
|
|
RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/20/08 |
Boston
|
|
NitroMed and Archemix to Merge
|
Robert Buderi |
11/18/08 |
Boston
|
|
Akamai Acquires Acerno, Archemix Adds Eli Lilly to Partner List, Sermo Signs Up Bloomberg Subscribers, & More Boston-Area Deals News
|
Rebecca Zacks |
10/27/08 |
Boston
|
|
Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/22/08 |
Boston
|
|
Archemix Looks to Hitch Eli Lilly to Aptamer Express in New Deal
|
Ryan McBride |
10/20/08 |
Boston
|
|
IPO Market in Tailspin—Pogo Jet Latest to Pull Offering
|
Robert Buderi |
03/18/08 |
Boston
|
|
Evergreen Solar Plans Offering, ThingMagic Teams With Ford, Dynogen Reverse-Merges Onto the Market, & More
|
Rebecca Zacks |
02/12/08 |
Boston
|
|
Archemix Pulls IPO
|
Rebecca Zacks |
02/07/08 |
Boston
|
|
BG Medicine Pulls IPO
|
Rebecca Zacks |
01/24/08 |
Boston
|
|
Elixir, NameMedia, Archemix, and More: What’s on Tap for New England IPOs in 2008
|
Rebecca Zacks |
01/11/08 |
Boston
|
|
Archemix Sets IPO Terms
|
Rebecca Zacks |
10/23/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
